Marketplace · Netherlands

Healthcare & medical practice businesses for sale in Enschede

Healthcare & medical practice businesses in Enschede typically transact at 4.7x–7.0x EV/EBITDA, with a sector median of 5.8x in the Netherlands. Twente's high-tech anchor city (University of Twente).

Healthcare & medical practice in Enschede

Enschede (population ~160,000, Overijssel) anchors healthcare & medical practice transactions at a 5.8x EV/EBITDA median, with most defensible deals landing between 4.7x (conservative) and 7.0x (strong recurring revenue). Twente's high-tech anchor city (University of Twente). SMEs cluster in MedTech, advanced manufacturing, IT and engineering; spin-off deal flow attracts PE and strategic buyers, with cross-border German interest.

No live listings yet

Upswitch is anonymity-by-design — new healthcare & medical practice dossiers in Enschede surface here as soon as they pass advisor validation. Subscribe to the alert and we'll notify you within hours of the next listing going live.

Browse all listings

Typical deal mechanics

For a healthcare & medical practice SME in Enschede with normalised EBITDA above €200k, expect the headline price to anchor on a 5.8x EV/EBITDA multiple, with a working-capital peg, 5–15% escrow, and (in 35–45% of deals) an earn-out tied to year-one EBITDA or customer retention. Cross-border buyer interest from Belgian acquirers is consistently elevated.

Why Enschede

Twente's high-tech anchor city (University of Twente). SMEs cluster in MedTech, advanced manufacturing, IT and engineering; spin-off deal flow attracts PE and strategic buyers, with cross-border German interest. For healthcare & medical practice specifically, Enschede's buyer pool typically includes regional family businesses, Benelux-wide strategic acquirers, and (for deals above ~€2m EV) PE-backed roll-up platforms.

Frequently asked

What's a typical EBITDA multiple for healthcare & medical practice businesses in Enschede?: In the Netherlands, healthcare & medical practice transactions land at 4.7x–7.0x EV/EBITDA, with a median around 5.8x. Enschede's deal flow trends close to the national figure, with 7.0x mostly reserved for businesses with recurring revenue or strong customer retention.
How do I list my healthcare & medical practice business for sale in Enschede anonymously?: Run a free Upswitch valuation, publish an anonymous business card (no photo upload, identity revealed only post-NDA), and an advisor introduces qualified buyers. The listing inherits your valuation as the anchor — no separate sale memorandum required.
Who typically buys healthcare & medical practice businesses in Enschede?: Dutch family businesses doing roll-up acquisitions, strategic acquirers from the broader Benelux corridor, and PE-backed platforms for transactions above ~€2m EV. Cross-border buyer interest from Belgium is consistently present.

Other sectors in Enschede

Healthcare & medical practice in other Dutch cities

Go deeper

Healthcare & medical practice in Enschede

Typical deal mechanics

Why Enschede

Frequently asked

What's a typical EBITDA multiple for healthcare & medical practice businesses in Enschede?

In the Netherlands, healthcare & medical practice transactions land at 4.7x–7.0x EV/EBITDA, with a median around 5.8x. Enschede's deal flow trends close to the national figure, with 7.0x mostly reserved for businesses with recurring revenue or strong customer retention.

How do I list my healthcare & medical practice business for sale in Enschede anonymously?

Run a free Upswitch valuation, publish an anonymous business card (no photo upload, identity revealed only post-NDA), and an advisor introduces qualified buyers. The listing inherits your valuation as the anchor — no separate sale memorandum required.

Who typically buys healthcare & medical practice businesses in Enschede?

Dutch family businesses doing roll-up acquisitions, strategic acquirers from the broader Benelux corridor, and PE-backed platforms for transactions above ~€2m EV. Cross-border buyer interest from Belgium is consistently present.